Progesterone Congeners

"Progesterone Congeners" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Steroidal compounds related to PROGESTERONE, the major mammalian progestational hormone. Progesterone congeners include important progesterone precursors in the biosynthetic pathways, metabolites, derivatives, and synthetic steroids with progestational activities.

Descriptor ID	D045167
MeSH Number(s)	D06.472.334.851.687
Concept/Terms	Progesterone Congeners Progesterone Congeners Progestational Hormones, Synthetic Progestational Hormones, Synthetic Synthetic Progestational Hormones Progestin Analogs Progestogens, Synthetic Synthetic Progestogens Progestins, Synthetic Progestational Hormone Analogues Progestin Analogues Progestagens, Synthetic Synthetic Progestagens Progestational Hormone Analogs Synthetic Progestins

Below are MeSH descriptors whose meaning is more general than "Progesterone Congeners".

Chemicals and Drugs [D]
Hormones, Hormone Substitutes, and Hormone Antagonists [D06]
Hormones [D06.472]
Gonadal Hormones [D06.472.334]
Gonadal Steroid Hormones [D06.472.334.851]
Progesterone Congeners [D06.472.334.851.687]

Below are MeSH descriptors whose meaning is related to "Progesterone Congeners".

Below are MeSH descriptors whose meaning is more specific than "Progesterone Congeners".

Progesterone Congeners
Pregnenolone
Progesterone

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Progesterone Congeners" by people in this website by year, and whether "Progesterone Congeners" was a major or minor topic of these publications.

Bar chart showing 10 publications over 6 distinct years, with a maximum of 3 publications in 2003

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	0	1
2000	1	0	1
2002	2	0	2
2003	2	1	3
2007	1	0	1
2010	1	1	2

Below are the most recent publications written about "Progesterone Congeners" by people in Profiles.

Edlefsen KL, Jackson RD, Prentice RL, Janssen I, Rajkovic A, O'Sullivan MJ, Anderson G. The effects of postmenopausal hormone therapy on serum estrogen, progesterone, and sex hormone-binding globulin levels in healthy postmenopausal women. Menopause. 2010 May-Jun; 17(3):622-9.

View in: PubMed
Harper M, Thom E, Klebanoff MA, Thorp J, Sorokin Y, Varner MW, Wapner RJ, Caritis SN, Iams JD, Carpenter MW, Peaceman AM, Mercer BM, Sciscione A, Rouse DJ, Ramin SM, Anderson GD. Omega-3 fatty acid supplementation to prevent recurrent preterm birth: a randomized controlled trial. Obstet Gynecol. 2010 Feb; 115(2 Pt 1):234-242.

View in: PubMed
Rouse DJ, Caritis SN, Peaceman AM, Sciscione A, Thom EA, Spong CY, Varner M, Malone F, Iams JD, Mercer BM, Thorp J, Sorokin Y, Carpenter M, Lo J, Ramin S, Harper M, Anderson G. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med. 2007 Aug 02; 357(5):454-61.

View in: PubMed
Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, LaCroix AZ, LeBoff M, Lewis CE, McGowan J, Neuner J, Pettinger M, Stefanick ML, Wactawski-Wende J, Watts NB. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA. 2003 Oct 01; 290(13):1729-38.

View in: PubMed
Woo J, Lau E, Ho SC, Cheng F, Chan C, Chan AS, Haines CJ, Chan TY, Li M, Sham A. Comparison of Pueraria lobata with hormone replacement therapy in treating the adverse health consequences of menopause. Menopause. 2003 Jul-Aug; 10(4):352-61.

View in: PubMed
Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003 May 28; 289(20):2651-62.

View in: PubMed
Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002 Jul 17; 288(3):321-33.

View in: PubMed
Corson SL. HRT: forever or never? Int J Fertil Womens Med. 2002 Jul-Aug; 47(4):150-1.

View in: PubMed
Silberstein SD, de Ligni?res B. Migraine, menopause and hormonal replacement therapy. Cephalalgia. 2000 Apr; 20(3):214-21.

View in: PubMed
Corson SL. Increased risk from third-generation progestogens: fuzzy logic or fuzzy science? J Reprod Med. 1996 Sep; 41(9):711-2.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement